ABN401 |
Katalog-Nr.GC65894 |
ABN401 ist ein hochpotenter und selektiver ATP-kompetitiver c-MET-Inhibitor mit einem IC50-Wert von 10 nM. ABN401 hat eine zytotoxische AktivitÄt gegen MET-abhÄngige Krebszellen. ABN401 kann die c-MET-Phosphorylierung in Tumorgeweben hemmen. ABN401 kann fÜr die Erforschung von Krebserkrankungen verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2242563-15-9
Sample solution is provided at 25 µL, 10mM.
ABN401 is a highly potent and selective ATP-competitive c-MET inhibitor with an IC50 value of 10 nM. ABN401 has cytotoxic activity against MET-addicted cancer cells. ABN401 can inhibit c-MET phosphorylation in tumor tissues. ABN401 can be used for researching anticancer[1].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *